Healthcare Knuggets
Feb 24, 2026 Email 1: Subject: How lobbyist strategies are changing under Trump’s FDA Good morning, Discover how the approach of drugmaker lobbyists to the FDA is shifting under the Trump administration. Traditionally, FDA decisions about drugs were shielded from political influence. However, now, the strategy focuses on “currying favor”
